Skip to main content
. 2019 Feb 11;100(4):808–815. doi: 10.4269/ajtmh.17-0982

Figure 1.

Figure 1.

Insulin-like growth factor-I (IGF-I) and IGF-binding protein 3 (IGFBP3) levels in human subjects from the visceral leishmaniasis (VL)-endemic area and their correlation with laboratory parameters in the active VL group. The IGF-I level (ng/mL) (A), IGF-I index (B), IGFBP3 level (µg/mL) (C), and IGFBP3 index (D) in patients with active VL and cured VL and asymptomatic Leishmania (L.) infantum–infected (C DTH+ [control delayed-type hypersensitivity]) individuals and healthy noninfected (C DTH−) subjects from the VL-endemic area. *P < 0.05 (Kruskal–Wallis and Dunn’s tests) compared with other groups. **P < 0.05 (Kruskal–Wallis and Dunn’s tests) compared with the C DTH− group. Correlations between hemoglobin concentration (g/dL) and the IGF-I index (E), hemoglobin concentration (g/dL) and IGFBP3 index (F) in the active VL group using Pearson’s test.